​

1831: Samuel Hahnemann prevented and treated cholera during the 1831 Asiatic cholera epidemic

1849: Dr. Clemens von Boenninghausen treated and prevented “untold” numbers of cholera infections during the 1849 European epidemic. While a death rate of 54-90% occurred with conventional treatment, Boenninghausen’s patients had a mortality rate of only 5-16%.

1907: Dr Eaton, 2806 persons were given Variolinum 30 CH by Dr. Eaton. 547 persons had definite exposure to small pox. Only 14 people got the infection, which means the prophylaxis was 97% effective

Influenza

1918-1920 Influenza (Spanish flu) epidemic in the US. The general mortality was 30%. Death rate among those treated homeopathically was 1%.

Brazil 2009-10: A double blind, randomized, placebo controlled with 600 children ages 1-5 was condicted. One group received a homeopathic complex called ARI, another received a homeopathic remedy made from Influenza A and a third received placebo for 30 days. The children were monitored for 12 months. No deaths or injuries were reported. The HP group was found to be least affected by flus. 

The researchers concluded that the protocol “…minimized the frequency of symptomatic episodes of the flu. Besides effectiveness, HP presents additional benefit of low cost and absence of adverse effects.” (Published in the International Journal of High Dilution Research 2011; 10(36):174-176.)

Poliomyelitis

1800s: Dr. Grimmer of Chicago: 5,000 young children treated with a homeoprophylactic. None developed polio.

1850: During an epidemic of poliomyelitis, Dr. Taylor Smith of Johannesburg, South Africa protected 82 people with a homeoprophylactic. Of these people, 12 came into direct contact with disease. None were infected.

1956-58: Dr. Eisfelder treated over 6,000 children with a homeoprophylactic. No cases of polio were reported in the group and no side-effects were observed.  

1957: A severe poliomyelitis epidemic occurred in Buenos Aires. The majority of homoeopathic doctors prescribed a known homeoprophylactic as a preventative. Drug stores distributed thousands of doses to the public. None of those who used the prophylactic registered a case of contagion.

1975: During another poliomyelitis epidemic in Buenos Aires, 40,000 were given a known homeoprophylactic for the disease. None developed poliomyelitis. 

Meningococcal Disease

Brazil, 1974: Outbreak of meningococcal disease. Mening 30CH was given to 18,640 children – 4 cases of meningitis, no death. 6,340 were not protected – 32 cases of meningitis

12 months later another outbreak happened: 65,826 protected – 4 cases of meningitis, no death, 23,532 not protected, 20 cases of meningitis

Whooping Cough

1987: Small clinical trial: 5 years, 82% of children protected, 5% infected with pertussis, 13% with other coughs

2004: Dr. Golden, 15-year study, HP group 86% protected

2012: Irish trial, 112 children 1 -2 months of age, those given homeoprophylactics for childhood diseases, including whooping cough, were less likely to experience severe symptoms of the diseases if contracted than the vaccinated comparison group

Cuba, 2007-8: 2.3 million treated in late 2007 re annual leptospirosis epidemic. Remaining 8.8 million were untreated.  

84% decrease in disease incidence, complete control of the epidemic.

The protective effect continued into 2008 with an 84% reduction in leptospirosis cases for the treated areas though no further prophylactic had been given. Leptospirosis infections in untreated areas increased by 22%.

​

2014: A re-evaluation of the above 2007-8 Cuban leptospirosis intervention was published. Results “supported previous conclusions that homeoprophylaxis can be used to effectively immunize people against targeted infectious diseases such as leptospirosis.”

Japanese Encephalitis is one of several important viral encephalitis diseases world-wide. It is an emerging disease in India and primarily affects children under age 15. It is the leading cause of Acute Encephalitis Syndrome (AES) in Asia. The virus is transmitted with mosquitoes and the disease is fatal in about 30% of cases with another 30-50% suffering long-term serious neurological sequelae. 

Over the past 60 years, it has been estimated that JE has infected 10 million children globally, killing 3 million and causing long-term disability in 4 million. Andra Pradesh, a state in Western India, has about 40 million children. First outbreaks of JE were reported in 1979. In 1999 recorded J.E. cases were 5308, and 1511 children died. The government chose homeoprophylaxis in 1999, due to ineffective vaccines and problems with distribution. 20 million children were treated with a three remedy protocol of Belladonna, Calcarea carbonica and Tuberculinum. 

Mortality and morbidity rates of J.E. fell drastically. (I learned about this very interesting study at an international conference on homeoprophylaxis from two of the actual medical doctors involved in the study.)

2000: 343 cases with 72 deaths

2001: Only 30 cases with 4 deaths

2002: Only 18 cases but no deaths

2003 and 2004 no cases were recorded.

Dr. Isaac Golden, PhD, Australia, conducted a long-term study of using homeoprophylaxis over fifteen years, from 1985 – 2005 with 3000 children. He used three groups of children, one group of fully vaccinated children, one with unvaccinated children and one with children who were given homeoprophylaxis. Long-term health outcomes showed that the children who received homeoprophylaxis were not only protected against infections that vaccines are used for by 90% which is comparable to regualr vaccination, but that they were the healthiest children of the tree. The fully vaccinated children were the least healthy, with the highest numbers of infections, respiratory issues, allergies and developmental and behavioral problem. 

You can read a more detailed article by Dr. Golden about HP here. 

Also see his PhD thesis here. 

​See books by Isaac Golden here.